Glaxo boosted by soaring demand for its shingles vaccine and Covid-19 treatment

Pain relief: In a big boost for CEO Emma Walmsley (pictured), GSK raised its sales and profit forecasts for the second time this year
Glaxo buoyed by growing demand for its shingles vaccine and Covid-19 treatment By Archie Mitchell for the Daily Mail Published: 22:10 GMT, November 2, 2022 | Updated: 22:28 GMT, November 2, 2022 Glaxosmithkline has been buoyed by growing demand for... Read more

Glaxo hails 'truly exceptional' results in respiratory virus vaccine trial

Test boost: A phase III clinical study of GSK's jab for RSV showed that the vaccine caused a 94.1% reduction in the severe version of the disease
Boost for Glaxo as pharma giant hails ‘truly exceptional’ results in key respiratory virus vaccine trial By Calum Muirhead for the Daily Mail Published: 22:36 BST, October 13, 2022 | Updated: 22:36 BST, October 13, 2022 GSK hailed a major... Read more

Glaxo boosted as US says yes to whooping cough jab for unborn babies 

Boss: US regulators' decision to approve Boostrix vaccine will come as a relief to pressured Glaxo CEO Dame Emma Walmsley (pictured)
GlaxoSmithKline Strengthens as US Regulators Say Yes to Pertussis Vaccine for Unborn Babies By City & Finance Reporter for the Daily Mail Published: 22:01 BST, October 10, 2022 | Updated: 22:01 BST, October 10, 2022 GlaxoSmithKline CEO Emma Walmsley got... Read more

Unilever chief Alan Jope set to step down after failed Glaxo bid

Difficult holding: Unilever CEO Alan Jope (pictured) has overseen a flat share price
Unilever boss Alan Jope is set to resign after a failed £50bn bid to acquire Glaxo’s consumer healthcare business By John Paul Ford Rojas for The Daily Mail Published: 22:11 BST, September 26, 2022 | Updated: 22:11 BST, September 26,... Read more